PPARD and Sepsis: Application of a PPARβ/δ agonist significantly improved survival in polymicrobial sepsis by a mechanism that might involve activation of Akt, inhibition of the MAPK-ERK1/2-signaling pathway, and subsequent suppression of NF-κB activity [106].